These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 12398906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
    Kamei J, Saitoh A, Kasuya Y.
    Neurosci Lett; 1995 Aug 25; 196(3):169-72. PubMed ID: 7501275
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J, Zushida K, Ohsawa M, Nagase H.
    Eur J Pharmacol; 2000 Mar 10; 391(1-2):91-6. PubMed ID: 10720639
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
    Kamei J, Kawai K, Mizusuna A, Saitoh A, Morita K, Narita M, Tseng LF, Nagase H.
    Eur J Pharmacol; 1997 Mar 12; 322(1):27-30. PubMed ID: 9088866
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.
    Neurosci Lett; 1994 Jan 03; 165(1-2):141-3. PubMed ID: 8015716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test.
    Choi SS, Han KJ, Lee HK, Han EJ, Suh HW.
    Pharmacol Biochem Behav; 2003 May 03; 75(2):447-57. PubMed ID: 12873637
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J, Kashiwazaki T, Hitosugi H, Nagase H.
    Eur J Pharmacol; 1997 May 12; 326(1):31-6. PubMed ID: 9178652
    [Abstract] [Full Text] [Related]

  • 20. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 12; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.